OpenVSafe by OpenVAERS
Search V-safe

ZQ9-11179-23454

2 vaccinations 4 coded responses 16 check-ins 3 free-text entries 3 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
066 / CT
Registered
2022-09-05
Relationship
Child or adolescent in my care
Guardian
6VP-99680-31471
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-09-03
    Dose 1 — Pfizer-BioNTech
  2. 2022-09-05
    Registered in v-safe
  3. 2022-09-05
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-09-06
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-09-09
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-09-19
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  7. 2022-09-24
    Survey response — day 21, dose 1, under 3
    MedDRA: Cough, Rhinorrhoea — Feeling: Fair
    Free text: Runny nose cough
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-09-27
    Dose 2 — Pfizer-BioNTech
  9. 2022-10-01
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-10-02
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  11. 2022-10-03
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  12. 2022-10-06
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  13. 2022-10-11
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  14. 2022-10-18
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  15. 2022-10-27
    Survey response — day 28, dose 2, under 3
    MedDRA: Cough, Pyrexia — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Cough and fever
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-10-27
    Report sent to call center — day 28, dose 2, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  17. 2022-10-28
  18. 2022-11-01
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  19. 2022-11-08
    Survey response — day 42, dose 2, under 3
    MedDRA: Conjunctivitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Pink eye
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-11-08
    Report sent to call center — day 42, dose 2, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  21. 2022-11-09
  22. 2022-11-09
  23. 2022-12-27
    Health check-in — 3 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  24. 2023-03-30
    Survey response — 6 months, dose 2, under 3
    MedDRA: Conjunctivitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  25. 2023-03-30
    Report sent to call center — 6 months, dose 2, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  26. 2023-03-31
  27. 2023-03-31
  28. 2023-03-31

Vaccinations

DoseDateManufacturerCo-administered
12022-09-03Pfizer-BioNTech No
22022-09-27Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-10-27 Unsuccessful
2022-11-08 Unsuccessful
2023-03-30 Unsuccessful

Free text

Release 12 (Under 3) — day 21, dose 1, under 3

2022-09-24

Symptoms: Runny nose cough

Release 12 (Under 3) — day 28, dose 2, under 3

2022-10-27

Symptoms: Cough and fever

Release 12 (Under 3) — day 42, dose 2, under 3

2022-11-08

Symptoms: Pink eye

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDConjunctivitis · · ✓
SDCough · · ✓
SDPyrexia · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…